Abstract
Mesoporous silica nanoparticles (MSNs) loaded with doxorubicin and then modified with hyaluronic acid (HA) and nanobody (DOX@MSNs-HA-11C12) is a pH- and redox-responsive drug delivery system, resulting in over 90% of LoVo cell apoptosis within 48 h.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have